Terug
28
Dagbereik
€ 52,02
€ 53,23
52-Weeksbereik
€ 46,01
€ 72,16
Volume
1.585.370
50D / 200D Gem.
€ 60,87
/
€ 57,62
Vorige Slotkoers
€ 52,43
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 112,3 | 0,3 |
| P/B | 4,3 | 3,0 |
| ROE % | 3,7 | 3,7 |
| Net Margin % | 6,0 | 3,8 |
| Rev Growth 5Y % | 7,0 | 10,0 |
| D/E | 0,2 | 0,2 |
Koersdoel Analisten
Hold
€ 69,33
+31.6%
Low: € 62,00
High: € 79,00
Forward K/W
26,20
Forward WPA
€ 1,98
WPA Groei (sch.)
+0,0%
Omzet Sch.
1,22B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 3,15
€ 3,10 – € 3,21
|
1,71B | 1 |
| FY2029 |
€ 3,03
€ 2,98 – € 3,08
|
1,53B | 1 |
| FY2028 |
€ 2,52
€ 2,22 – € 2,76
|
1,43B | 3 |
No quarterly estimates available
Dividend History
7 yr streakYield
0,01%
Payout Ratio
0,69%
Growth (3Y)
-37,00%
Growth (5Y)
-24,21%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Feb 13, 2026 | Feb 27, 2026 | € 0,08 | 0,53% |
| Nov 17, 2025 | Nov 28, 2025 | € 0,08 | 0,55% |
| Aug 18, 2025 | Aug 29, 2025 | € 0,08 | 0,60% |
| May 19, 2025 | May 30, 2025 | € 0,08 | 0,65% |
| Feb 14, 2025 | Feb 28, 2025 | € 0,08 | 0,49% |
| Nov 08, 2024 | Nov 22, 2024 | € 0,08 | 0,42% |
| Aug 19, 2024 | Aug 30, 2024 | € 0,08 | 0,43% |
| May 10, 2024 | May 24, 2024 | € 0,08 | 0,40% |
| Feb 09, 2024 | Feb 26, 2024 | € 0,08 | 0,47% |
| Nov 09, 2023 | Nov 24, 2023 | € 0,08 | 0,56% |
| Aug 17, 2023 | Sep 01, 2023 | € 0,08 | 0,40% |
| May 12, 2023 | May 26, 2023 | € 0,08 | 0,39% |
| Feb 10, 2023 | Feb 27, 2023 | € 0,08 | 0,42% |
| Nov 10, 2022 | Nov 28, 2022 | € 0,32 | 0,38% |
| Aug 12, 2022 | Aug 29, 2022 | € 0,32 | 0,34% |
| May 13, 2022 | May 27, 2022 | € 0,32 | 0,35% |
| Feb 10, 2022 | Feb 25, 2022 | € 0,32 | 0,30% |
| Nov 10, 2021 | Nov 26, 2021 | € 0,32 | 0,25% |
| Aug 13, 2021 | Aug 27, 2021 | € 0,32 | 0,27% |
| May 14, 2021 | May 28, 2021 | € 0,32 | 0,32% |
Belangrijkste Punten
Revenue grew 6,98% annually over 5 years — modest growth
Earnings declined -56,34% over the past year
ROE of 3,68% is below average
Debt/Equity of 0,23 — conservative balance sheet
Generating 256,55M in free cash flow
P/E of 112,31 — premium valuation
Groei
Revenue Growth (5Y)
6,98%
Revenue (1Y)5,23%
Earnings (1Y)-56,34%
FCF Growth (3Y)8,95%
Kwaliteit
Return on Equity
3,68%
ROIC3,25%
Net Margin6,02%
Op. Margin8,38%
Veiligheid
Debt / Equity
0,23
Current Ratio3,46
Interest Coverage12,02
Waardering
P/E Ratio
112,31
Forward P/E26,20
P/B Ratio4,30
EV/EBITDA83,37
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,23% | Revenue Growth (3Y) | 3,58% |
| Earnings Growth (1Y) | -56,34% | Earnings Growth (3Y) | -49,27% |
| Revenue Growth (5Y) | 6,98% | Earnings Growth (5Y) | -14,97% |
| Profitability | |||
| Revenue (TTM) | 1,22B | Net Income (TTM) | 73,40M |
| ROE | 3,68% | ROA | 2,87% |
| Gross Margin | 64,80% | Operating Margin | 8,38% |
| Net Margin | 6,02% | Free Cash Flow (TTM) | 256,55M |
| ROIC | 3,25% | FCF Growth (3Y) | 8,95% |
| Safety | |||
| Debt / Equity | 0,23 | Current Ratio | 3,46 |
| Interest Coverage | 12,02 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | 0,69% |
| Dividend Growth (3Y) | -37,00% | Dividend Growth (5Y) | -24,21% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 112,31 | Forward P/E | 26,20 |
| P/B Ratio | 4,30 | P/S Ratio | 6,76 |
| PEG Ratio | -1,97 | Forward PEG | N/A |
| EV/EBITDA | 83,37 | Fwd EV/EBITDA | 23,32 |
| Forward P/S | 6,73 | Fwd Earnings Yield | 3,82% |
| FCF Yield | 3,11% | ||
| Market Cap | 8,24B | Enterprise Value | 8,53B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,22B | 1,16B | 1,14B | 1,11B | 931,03M |
| Net Income | 73,40M | 168,11M | 285,26M | 272,05M | 140,41M |
| EPS (Diluted) | 0,46 | 1,05 | 1,76 | 1,66 | 0,87 |
| Gross Profit | 790,27M | 769,73M | 769,82M | 756,50M | 632,85M |
| Operating Income | 102,26M | 206,69M | 298,94M | 296,59M | 237,30M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,56B | 2,70B | 2,64B | 2,29B | 2,26B |
| Total Liabilities | 639,06M | 635,02M | 672,18M | 593,79M | 691,72M |
| Shareholders' Equity | 1,92B | 2,07B | 1,97B | 1,70B | 1,56B |
| Total Debt | 444,06M | 419,54M | 454,97M | 325,97M | 420,55M |
| Cash & Equivalents | 162,19M | 151,79M | 180,57M | 172,57M | 199,09M |
| Current Assets | 608,30M | 617,42M | 621,48M | 605,56M | 510,61M |
| Current Liabilities | 175,85M | 159,38M | 128,51M | 176,02M | 152,28M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#884 of 1052
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026